Global Cattle and Sheep Vaccine market size is predicted to grow from US$ 1942 million in 2025 to US$ 2873 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

Global Cattle and Sheep Vaccine Market Size, Share and Analysis

The global Cattle and Sheep Vaccine market size is predicted to grow from US$ 1942 million in 2025 to US$ 2873 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031. Cattle and sheep vaccines are vaccines that are specifically designed for use in cattle and sheep to prevent various diseases that can affect these animals. Some of the commonly used cattle and sheep vaccines include those for diseases such as Foot and Mouth Disease (FMD), Brucellosis, Anthrax, and Clostridial diseases like Tetanus and Blackleg. These vaccines are typically administered via injection ingestion and are an important tool for maintaining the health and productivity of cattle and sheep herds. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Cattle and Sheep Vaccine Industry Forecast looks at past sales and reviews total world Cattle and Sheep Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Cattle and Sheep Vaccine sales for 2025 through 2031. With Cattle and Sheep Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cattle and Sheep Vaccine industry. This Insight Report provides a comprehensive analysis of the global Cattle and Sheep Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cattle and Sheep Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Cattle and Sheep Vaccine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cattle and Sheep Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cattle and Sheep Vaccine. This report presents a comprehensive overview, market shares, and growth opportunities of Cattle and Sheep Vaccine market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Live Attenuated Vaccines &nbsp;&nbsp;&nbsp; Inactivated Vaccines &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Cattle &nbsp;&nbsp;&nbsp; Sheep This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Zoetis &nbsp;&nbsp;&nbsp; Boehringer Ingelheim &nbsp;&nbsp;&nbsp; Ceva &nbsp;&nbsp;&nbsp; CAHIC &nbsp;&nbsp;&nbsp; HVRI &nbsp;&nbsp;&nbsp; Ringpu Biology &nbsp;&nbsp;&nbsp; Yebio &nbsp;&nbsp;&nbsp; DHN &nbsp;&nbsp;&nbsp; WINSUN &nbsp;&nbsp;&nbsp; Elanco &nbsp;&nbsp;&nbsp; Virbac &nbsp;&nbsp;&nbsp; Jinyu Bio-Technology &nbsp;&nbsp;&nbsp; ChengDu Tecbond &nbsp;&nbsp;&nbsp; CAVAC &nbsp;&nbsp;&nbsp; Kyoto Biken Laboratories Key Questions Addressed in this Report What is the 10-year outlook for the global Cattle and Sheep Vaccine market? What factors are driving Cattle and Sheep Vaccine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Cattle and Sheep Vaccine market opportunities vary by end market size? How does Cattle and Sheep Vaccine break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Cattle and Sheep Vaccine Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Cattle and Sheep Vaccine by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Cattle and Sheep Vaccine by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Cattle and Sheep Vaccine Segment by Type &nbsp;2.2.1 Live Attenuated Vaccines &nbsp;2.2.2 Inactivated Vaccines &nbsp;2.2.3 Other &nbsp;2.3 Cattle and Sheep Vaccine Sales by Type &nbsp;2.3.1 Global Cattle and Sheep Vaccine Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Cattle and Sheep Vaccine Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Cattle and Sheep Vaccine Sale Price by Type (2020-2025) &nbsp;2.4 Cattle and Sheep Vaccine Segment by Application &nbsp;2.4.1 Cattle &nbsp;2.4.2 Sheep &nbsp;2.5 Cattle and Sheep Vaccine Sales by Application &nbsp;2.5.1 Global Cattle and Sheep Vaccine Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Cattle and Sheep Vaccine Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Cattle and Sheep Vaccine Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Cattle and Sheep Vaccine Breakdown Data by Company &nbsp;3.1.1 Global Cattle and Sheep Vaccine Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Cattle and Sheep Vaccine Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Cattle and Sheep Vaccine Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Cattle and Sheep Vaccine Revenue by Company (2020-2025) &nbsp;3.2.2 Global Cattle and Sheep Vaccine Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Cattle and Sheep Vaccine Sale Price by Company &nbsp;3.4 Key Manufacturers Cattle and Sheep Vaccine Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Cattle and Sheep Vaccine Product Location Distribution &nbsp;3.4.2 Players Cattle and Sheep Vaccine Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Cattle and Sheep Vaccine by Geographic Region &nbsp;4.1 World Historic Cattle and Sheep Vaccine Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Cattle and Sheep Vaccine Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Cattle and Sheep Vaccine Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Cattle and Sheep Vaccine Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Cattle and Sheep Vaccine Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Cattle and Sheep Vaccine Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Cattle and Sheep Vaccine Sales Growth &nbsp;4.4 APAC Cattle and Sheep Vaccine Sales Growth &nbsp;4.5 Europe Cattle and Sheep Vaccine Sales Growth &nbsp;4.6 Middle East & Africa Cattle and Sheep Vaccine Sales Growth 5 Americas &nbsp;5.1 Americas Cattle and Sheep Vaccine Sales by Country &nbsp;5.1.1 Americas Cattle and Sheep Vaccine Sales by Country (2020-2025) &nbsp;5.1.2 Americas Cattle and Sheep Vaccine Revenue by Country (2020-2025) &nbsp;5.2 Americas Cattle and Sheep Vaccine Sales by Type (2020-2025) &nbsp;5.3 Americas Cattle and Sheep Vaccine Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Cattle and Sheep Vaccine Sales by Region &nbsp;6.1.1 APAC Cattle and Sheep Vaccine Sales by Region (2020-2025) &nbsp;6.1.2 APAC Cattle and Sheep Vaccine Revenue by Region (2020-2025) &nbsp;6.2 APAC Cattle and Sheep Vaccine Sales by Type (2020-2025) &nbsp;6.3 APAC Cattle and Sheep Vaccine Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Cattle and Sheep Vaccine by Country &nbsp;7.1.1 Europe Cattle and Sheep Vaccine Sales by Country (2020-2025) &nbsp;7.1.2 Europe Cattle and Sheep Vaccine Revenue by Country (2020-2025) &nbsp;7.2 Europe Cattle and Sheep Vaccine Sales by Type (2020-2025) &nbsp;7.3 Europe Cattle and Sheep Vaccine Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Cattle and Sheep Vaccine by Country &nbsp;8.1.1 Middle East & Africa Cattle and Sheep Vaccine Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Cattle and Sheep Vaccine Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Cattle and Sheep Vaccine Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Cattle and Sheep Vaccine Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Cattle and Sheep Vaccine &nbsp;10.3 Manufacturing Process Analysis of Cattle and Sheep Vaccine &nbsp;10.4 Industry Chain Structure of Cattle and Sheep Vaccine 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Cattle and Sheep Vaccine Distributors &nbsp;11.3 Cattle and Sheep Vaccine Customer 12 World Forecast Review for Cattle and Sheep Vaccine by Geographic Region &nbsp;12.1 Global Cattle and Sheep Vaccine Market Size Forecast by Region &nbsp;12.1.1 Global Cattle and Sheep Vaccine Forecast by Region (2026-2031) &nbsp;12.1.2 Global Cattle and Sheep Vaccine Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Cattle and Sheep Vaccine Forecast by Type (2026-2031) &nbsp;12.7 Global Cattle and Sheep Vaccine Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Merck &nbsp;13.1.1 Merck Company Information &nbsp;13.1.2 Merck Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.1.3 Merck Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Merck Main Business Overview &nbsp;13.1.5 Merck Latest Developments &nbsp;13.2 Zoetis &nbsp;13.2.1 Zoetis Company Information &nbsp;13.2.2 Zoetis Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.2.3 Zoetis Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Zoetis Main Business Overview &nbsp;13.2.5 Zoetis Latest Developments &nbsp;13.3 Boehringer Ingelheim &nbsp;13.3.1 Boehringer Ingelheim Company Information &nbsp;13.3.2 Boehringer Ingelheim Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.3.3 Boehringer Ingelheim Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Boehringer Ingelheim Main Business Overview &nbsp;13.3.5 Boehringer Ingelheim Latest Developments &nbsp;13.4 Ceva &nbsp;13.4.1 Ceva Company Information &nbsp;13.4.2 Ceva Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.4.3 Ceva Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Ceva Main Business Overview &nbsp;13.4.5 Ceva Latest Developments &nbsp;13.5 CAHIC &nbsp;13.5.1 CAHIC Company Information &nbsp;13.5.2 CAHIC Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.5.3 CAHIC Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 CAHIC Main Business Overview &nbsp;13.5.5 CAHIC Latest Developments &nbsp;13.6 HVRI &nbsp;13.6.1 HVRI Company Information &nbsp;13.6.2 HVRI Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.6.3 HVRI Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 HVRI Main Business Overview &nbsp;13.6.5 HVRI Latest Developments &nbsp;13.7 Ringpu Biology &nbsp;13.7.1 Ringpu Biology Company Information &nbsp;13.7.2 Ringpu Biology Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.7.3 Ringpu Biology Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Ringpu Biology Main Business Overview &nbsp;13.7.5 Ringpu Biology Latest Developments &nbsp;13.8 Yebio &nbsp;13.8.1 Yebio Company Information &nbsp;13.8.2 Yebio Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.8.3 Yebio Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Yebio Main Business Overview &nbsp;13.8.5 Yebio Latest Developments &nbsp;13.9 DHN &nbsp;13.9.1 DHN Company Information &nbsp;13.9.2 DHN Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.9.3 DHN Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 DHN Main Business Overview &nbsp;13.9.5 DHN Latest Developments &nbsp;13.10 WINSUN &nbsp;13.10.1 WINSUN Company Information &nbsp;13.10.2 WINSUN Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.10.3 WINSUN Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 WINSUN Main Business Overview &nbsp;13.10.5 WINSUN Latest Developments &nbsp;13.11 Elanco &nbsp;13.11.1 Elanco Company Information &nbsp;13.11.2 Elanco Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.11.3 Elanco Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Elanco Main Business Overview &nbsp;13.11.5 Elanco Latest Developments &nbsp;13.12 Virbac &nbsp;13.12.1 Virbac Company Information &nbsp;13.12.2 Virbac Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.12.3 Virbac Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Virbac Main Business Overview &nbsp;13.12.5 Virbac Latest Developments &nbsp;13.13 Jinyu Bio-Technology &nbsp;13.13.1 Jinyu Bio-Technology Company Information &nbsp;13.13.2 Jinyu Bio-Technology Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.13.3 Jinyu Bio-Technology Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Jinyu Bio-Technology Main Business Overview &nbsp;13.13.5 Jinyu Bio-Technology Latest Developments &nbsp;13.14 ChengDu Tecbond &nbsp;13.14.1 ChengDu Tecbond Company Information &nbsp;13.14.2 ChengDu Tecbond Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.14.3 ChengDu Tecbond Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 ChengDu Tecbond Main Business Overview &nbsp;13.14.5 ChengDu Tecbond Latest Developments &nbsp;13.15 CAVAC &nbsp;13.15.1 CAVAC Company Information &nbsp;13.15.2 CAVAC Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.15.3 CAVAC Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 CAVAC Main Business Overview &nbsp;13.15.5 CAVAC Latest Developments &nbsp;13.16 Kyoto Biken Laboratories &nbsp;13.16.1 Kyoto Biken Laboratories Company Information &nbsp;13.16.2 Kyoto Biken Laboratories Cattle and Sheep Vaccine Product Portfolios and Specifications &nbsp;13.16.3 Kyoto Biken Laboratories Cattle and Sheep Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 Kyoto Biken Laboratories Main Business Overview &nbsp;13.16.5 Kyoto Biken Laboratories Latest Developments 14 Research Findings and Conclusion

Report	Global Cattle and Sheep Vaccine Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI49743

Buyer Information

Order Summary